Familial Parkinson’s disease: a hint to elucidate the mechanisms of nigral degeneration Nobutaka HattoriHirokazu KobayashiYoshikuni Mizuno Pages: iii2 - iii10
Aggregation of α-synuclein in the pathogenesis of Parkinson’s disease Takeshi Iwatsubo Pages: iii11 - iii14
New insights into Parkinson’s disease Kenny K. K. ChungValina L. DawsonTed M. Dawson Pages: iii15 - iii24
Pael receptor, endoplasmic reticulum stress, and Parkinson’s disease Ryosuke TakahashiYuzuru Imai Pages: iii25 - iii29
Environmental, life-style, and physical precursors of clinical Parkinson’s disease: recent findings from the Honolulu-Asia Aging Study Robert D. AbbottG. Webster RossHelen Petrovitch Pages: iii30 - iii39
Toward identification of susceptibility genes for sporadic Parkinson’s disease Tatsushi TodaYoshio MomoseHidetoshi Inoko Pages: iii40 - iii43
Do patients with Parkinson’s disease benefit from embryonic dopamine cell transplantation? Curt R. FreedMaureen A. LeeheyRobert E. Breeze Pages: iii44 - iii46
Does transcranial magnetic stimulation improve the motor symptoms of Parkinson disease? Sadatoshi TsujiNaoki Akamatsu Pages: iii47 - iii50